Disease landscape

Hypertension clinical trials

Get alerts when Hypertension trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-21

What changed in the last 30 days

117 trials changed in the last 30 days: 4 stopped, 51 with notable changes, 62 with minor changes only.

  1. Stopped

    NEPHRON · Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone · Hypertension and Chronic Kidney Disease

    Trial status changed: Recruiting → Withdrawn

    Also in this update: Primary completion date changed from estimate of Jul 2026 to Sep 17, 2026

    Sarfez Pharmaceuticals, Inc.Phase 3 NCT07223502 Registry history of NCT07223502 on ClinicalTrials.gov (opens the registry)

  2. Notable

    LAM-001 · Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

    Primary completion pushed from Jul 16, 2027 to Mar 2028

    Also in this update: Trial sites expanded: 3 → 32 locations; Study completion pushed from Aug 30, 2028 to Feb 2029; and 1 more change in the last 30 days

    IRulya Therapeutics Inc.Phase 2 NCT05798923 Registry history of NCT05798923 on ClinicalTrials.gov (opens the registry)

  3. Notable

    ACT-ON-ACUTE · Difference in Acute Responses of Vascular Function to Moderate-intensity and High-intensity Interval Training in Healthy and Prehypertensive Individuals

    Primary completion pushed from May 2026 to Dec 2026

    Also in this update: Study completion pushed from Jun 2026 to Dec 2026

    University of LjubljanaNot applicable NCT07048509 Registry history of NCT07048509 on ClinicalTrials.gov (opens the registry)

  4. Notable

    TELE-CVRM · Integrated, Digital, Nurse-led, Remote Monitoring Care Pathway for Cardiovascular Risk Management

    Primary completion pushed from Oct 1, 2027 to Mar 30, 2028

    Also in this update: Recruitment opened; Study completion moved earlier from Oct 1, 2030 to Mar 30, 2030

    Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Not specified NCT07208331 Registry history of NCT07208331 on ClinicalTrials.gov (opens the registry)

Show 62 trials with minor changes only
  1. Minor

    PreVail-PH2 · Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure · Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

    Primary completion pushed from Dec 2026 to Jun 2027

    Also in this update: Study completion pushed from Jul 1, 2028 to Jun 1, 2030

    Gradient Denervation TechnologiesNot applicable NCT06052072 Registry history of NCT06052072 on ClinicalTrials.gov (opens the registry)

  2. Minor

    The PULSE-LHD · Placebo-procedure Controlled Trial of the Enhancor System (PULmonary Artery Denervation) to Evaluate Safety and Efficacy · Combined Pre- and Post-capillary Pulmonary Hypertension Associated With Left Heart Disease

    Trial sites expanded: 13 → 16 locations

    And 1 more change in the last 30 days

    Pulnovo Medical, Inc.Not applicable NCT07214376 Registry history of NCT07214376 on ClinicalTrials.gov (opens the registry)

  3. Minor

    INSIDE-RH · Arterial Stiffness as a Tool to Investigate Adherence in Resistant Hypertension

    Study completion pushed from Jul 27, 2026 to Jan 25, 2027

    Also in this update: Primary completion date changed from estimate of Jul 27, 2026 to Mar 27, 2026

    Institut National de la Santé Et de la Recherche Médicale, FranceNot applicable NCT07207226 Registry history of NCT07207226 on ClinicalTrials.gov (opens the registry)

  4. Minor
    12 trials marked Unknown by the registry's verification sweep
    1. Minor

      Combined Effects of Isometric Wall Squats and High Intensity Interval Training on Rate Pressure Product in Normotensive and Pre-hypertensive Sedentary Adults

      Registry marked status Unknown (sponsor has not verified the record since Sep 2024); last known: Active, Not Recruiting

      Foundation University IslamabadNot applicable NCT06610006 Registry history of NCT06610006 on ClinicalTrials.gov (opens the registry)

      Changed

    Registry verification sweep

    Changed

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-10-19 NCT07880990 Behaviour Change Wheel Intervention to Promote Healthy Behaviors in Adults With… Fujian Medical University Union Hospital new
2026-10-16 NCT07878728 Text Message Support to Help Adults With Newly Diagnosed High Blood Pressure Control… GIFT University new
2026-10-16 NCT07879144 Digital Nudges to Improve Heart Health Actions After Community Screening in Malaysia… Cardiovascular Advancement and Research Excellence Institute new
2026-10-15 NCT07876895 Monitoring the Effectiveness and Safety of Antihypertensive Therapy With a Fixed-Dose… Bosnalijek D.D new
2026-10-14 NCT07874191 Retinal and Choroidal Microcirculation in Preeclampsia: An OCTA Study Muğla Sıtkı Koçman University new
2026-10-13 NCT07871500 Oliceridine Versus Sufentanil for Blood Pressure Control During Anesthesia Induction in… Xingguo Xu new Phase 4
2026-10-06 NCT07860437 Instructor Interpersonal Behaviours in Classical Pilates as a Pathway to Improve Blood… Instituto Politécnico de Leiria new
2026-10-02 NCT07855679 Pulmonary Embolism Registry From Short-Term Emergency to Long-Term Follow-Up and… Azienda Ospedaliero-Universitaria Careggi new
2026-10-02 NCT07853625 Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive… University of Health Sciences Lahore new
2026-10-01 NCT07851610 Right Heart and Lung Blood Flow During Exercise (RIGHT-NET 2.0) IRCCS SYNLAB SDN new

Active trials by phase

Early Phase 1
19
Phase 1
51
Phase 1/2
22
Phase 2
86
Phase 2/3
7
Phase 3
76
Phase 4
72
Not charted: 1,141 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Top sponsors by active trials in this area

Get alerts when Hypertension trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free

Narrower conditions

Active trials